Prostate Cancer - Results from #28060

Transurethral resection biopsy as part of a saturation biopsy protocol: A cohort study and review of the literature - Abstract May 5, 2011

The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration May 5, 2011

Decision tree-based modeling of androgen pathway genes and prostate cancer risk - Abstract May 5, 2011

Extended sampling at first biopsy improves cancer detection rate: Results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy - Abstract May 5, 2011

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities - Abstract May 4, 2011

Results of 125-Iodine seed implant with preplanning system in 250 patients with prostate cancer - Abstract May 4, 2011

Evaluation of inter-fraction prostate motion using kilovoltage cone beam computed tomography during radiotherapy - Abstract May 4, 2011

Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer - Abstract May 4, 2011

Design considerations for a novel MRI compatible manipulator for prostate cryoablation - Abstract May 4, 2011

Reverse stage shift at a tertiary care center: Escalating risk in men undergoing radical prostatectomy - Abstract May 4, 2011

Techniques for neurovascular bundle preservation during retropubic radical prostatectomy - Abstract May 4, 2011

Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: Active surveillance and focal targeted therapy - Abstract May 4, 2011

Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer - Abstract May 4, 2011

EAU 2011 - The PCA3 score accurately predicts tumor volume and might help in selecting prostate cancer patients for active surveillance - Session Highlights May 4, 2011

EAU 2011 - Interest of early confirmatory biopsies and centralized pathological review to select prostate cancer patients for active surveillance - Session Highlights May 4, 2011

EAU 2011 - Non-invasive diagnosis of prostate cancer from body fluids using a panel of tumor suppressor genes - Session Highlights May 4, 2011

EAU 2011 - Evaluation of different molecular markers for the detection of minimal residual disease in lymph nodes of patients undergoing radical prostatectomy and extended pelvic lymph node dissection (PLND) - Session Highlights May 4, 2011

Small prostate size and high grade disease-biology or artifact? - Abstract May 3, 2011

Inhibition of prostate cancer using RNA interference-directed knockdown of platelet-derived growth factor receptor - Abstract May 3, 2011

A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer - Abstract May 3, 2011

Page 1404 of 1435